Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

<ul>
<li>SG Micro launched Hongkong IPO to raise up to HK$4.6B. They are a leading analog IC company in China who design, develop and sell high-performance analog ICs and sensors.  </li>
<li>SG Micro intends to use the IPO proceeds to expand overseas sales network, investment &amp; acquisition opportunities, enhance R&amp;D capabilities and working capital.</li>
<li>Prima facie, in terms of the valuation that the company is seeking, the company seems overvalued. Investors can avoid the issue for now.</li>
</ul>


SG Micro launched Hongkong IPO to raise up to HK$4.6B. They are a leading analog IC company in China who design, develop and sell high-performance analog ICs and sensors.  
SG Micro intends to use the IPO proceeds to expand overseas sales network, investment &amp; acquisition opportunities, enhance R&amp;D capabilities and working capital.
Prima facie, in terms of the valuation that the company is seeking, the company seems overvalued. Investors can avoid the issue for now.


SG Micro IPO: Issue Valuation Sought Does Not Seem Analogous With Inherent Prospects